Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of TRPV4 mRNA | affects expression | 16483693
|
D002118 |
Calcium |
TRPV4 protein promotes the reaction [phorbol-12,13-didecanoate results in increased import of Calcium] | increases import|increases reaction | 18355916
|
D005419 |
Flavonoids |
Flavonoids results in decreased expression of TRPV4 mRNA | decreases expression | 18035473
|
C008876 |
phorbol-12,13-didecanoate |
phorbol-12,13-didecanoate binds to and results in increased activity of TRPV4 protein | affects binding|increases activity | 18587396
|
C008876 |
phorbol-12,13-didecanoate |
TRPV4 protein promotes the reaction [phorbol-12,13-didecanoate results in increased import of Calcium] | increases import|increases reaction | 18355916
|
C008876 |
phorbol-12,13-didecanoate |
phorbol-12,13-didecanoate binds to and results in increased activity of TRPV4 protein | affects binding|increases activity | 19029406
|
C008876 |
phorbol-12,13-didecanoate |
phorbol-12,13-didecanoate results in increased activity of TRPV4 protein | increases activity | 19075100
|
C025299 |
polyphenols |
polyphenols results in increased expression of TRPV4 mRNA | increases expression | 16293270
|
D012430 |
Ruthenium Red |
Ruthenium Red results in decreased activity of TRPV4 protein | decreases activity | 19075100
|
D017673 |
Sodium Chloride, Dietary |
Sodium Chloride, Dietary results in increased expression of TRPV4 protein | increases expression | 19075100
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of TRPV4 mRNA | increases expression | 20106945
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.18 | 11752688 14514962 15322242 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.90 | 18287403 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.71 | 16835633 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.17 | 11748828 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.29 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.17 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.91 | 15746008 |
OMIM:113500 |
BRACHYOLMIA TYPE 3 |
marker/mechanism |
|
| |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.68 | 20435547 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.99 | 16835633 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.49 | 18850075 16120746 18670907 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.38 | 16835633 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.19 | 16354765 15340226 8697196 12621046 15668235 |
MESH:D003110 |
Colonic Neoplasms |
|
polyphenols |
2.70 | 16293270 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.27 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 15322242 20055451 10048152 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.71 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
polyphenols |
4.18 | 19370779 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
4.18 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.93 | 11462148 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.61 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.28 | 16714409 15322242 18230668 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.25 | 10568697 9294722 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.19 | 11564622 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.76 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
3.25 | 20067830 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.97 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.44 | 10048152 11294989 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.58 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.20 | 15340226 16120746 12621046 |
OMIM:606071 |
HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC |
marker/mechanism |
|
| 20037586 20037587 20037588 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.42 | 18606429 8697196 16959395 16354765 15340226 |
MESH:D006973 |
Hypertension |
|
Sodium Chloride, Dietary |
6.13 | 18524855 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
6.13 | 18670907 18850075 |
MESH:D007249 |
Inflammation |
|
Flavonoids |
9.07 | 17296493 |
MESH:D007249 |
Inflammation |
|
polyphenols |
9.07 | 16366677 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
9.07 | 12878042 12200463 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.58 | 16580747 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Calcium |
5.42 | 16316344 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
1.24 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
polyphenols |
2.83 | 16698588 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
1.79 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
2.24 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
1.24 | 11884234 19555203 |
OMIM:156530 |
METATROPIC DYSPLASIA |
marker/mechanism |
|
| 20425821 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.21 | 12213967 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.49 | 14600291 |
MESH:D010009 |
Osteochondrodysplasias |
marker/mechanism |
|
| 18587396 |
MESH:D010024 |
Osteoporosis |
|
Calcium |
3.92 | 17882678 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.62 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.84 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.53 | 11118676 11222880 11896295 11399792 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.12 | 18990726 |
OMIM:181405 |
SCAPULOPERONEAL SPINAL MUSCULAR ATROPHY |
marker/mechanism |
|
| 20037587 20037588 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
2.14 | 16192470 |
OMIM:600175 |
SPINAL MUSCULAR ATROPHY, DISTAL, CONGENITAL NONPROGRESSIVE |
marker/mechanism |
|
| 20037588 |
MESH:C535797 |
Spondylometaphyseal dysplasia, Kozlowski type |
marker/mechanism |
|
| |
MESH:D013705 |
Temporomandibular Joint Disorders |
|
polyphenols |
5.63 | 17997062 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.28 | 12697716 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.97 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.62 | 15886252 |